Paolucci Michael E 4

What Happened
Michael E. Paolucci, a director of Orthofix Medical Inc. (OFIX), received an award of 14,965 deferred stock units on June 10, 2026. The grant was reported at $0.00 per unit (no cash exchanged), so the immediate transaction value is $0. These units are awards (not open-market purchases or sales).

Key Details

• Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely filing).
• Grant: 14,965 deferred stock units (code A); reporting price $0.00.
• Reported beneficial ownership after the grant: 89,320 shares/units (14,965 new DSUs + 73,541 previously reported DSUs + 814 shares from the company Stock Purchase Plan).
• Footnote F1: DSUs vest in full on the first anniversary of the grant (subject to continued service). Each DSU represents a contingent right to one share; vested DSUs will be settled and converted into common stock within 45 days after the reporting person's termination of service.
• Footnote F2: The 814 shares were acquired under Orthofix’s Stock Purchase Plan on 10/31/2025; purchases under the SPP are exempt from Section 16(b).

Context
This was an equity grant (deferred stock units), commonly used for director compensation and retention. Because DSUs vest over time and convert to common shares only upon vesting or specified events, they are not the same as immediately tradable shares. The grant itself is neither a purchase nor a sale of existing shares, and does not alone indicate the director’s market sentiment.